THE USE OF TUMOR-MARKERS IN GERM-CELL MALIGNANCIES

被引：11

作者：

BOSL, GJ

CHAGANTI, RSK

机构：

[1] MEM SLOAN KETTERING CANC CTR, DEPT PATHOL, CYTOGENET SERV, NEW YORK, NY 10021 USA

[2] CORNELL UNIV, COLL MED, DEPT MED, NEW YORK, NY 10021 USA

[3] CORNELL UNIV, COLL MED, GRAD SCH MED SCI, NEW YORK, NY 10021 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 03期

关键词：

D O I：

10.1016/S0889-8588(18)30169-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：573 / 587

页数：15

共 96 条

[11] VAB-6 - AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH GERM-CELL TUMORS [J].

BOSL, GJ ;

GLUCKMAN, R ;

GELLER, NL ;

GOLBEY, RB ;

WHITMORE, WF ;

HERR, H ;

SOGANI, P ;

MORSE, M ;

MARTINI, N ;

BAINS, M ;

MCCORMACK, P .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) :1493-1499

[12] CLINICAL RELEVANCE OF THE I(12P) MARKER CHROMOSOME IN GERM-CELL TUMORS [J].

BOSL, GJ ;

ILSON, DH ;

RODRIGUEZ, E ;

MOTZER, RJ ;

REUTER, VE ;

CHAGANTI, RSK .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (05) :349-355

[13]

BOSL GJ, 1988, CANCER RES, V48, P3524

[14] ALTERNATING CYCLES OF ETOPOSIDE PLUS CISPLATIN AND VAB-6 IN THE TREATMENT OF POOR-RISK PATIENTS WITH GERM-CELL TUMORS [J].

BOSL, GJ ;

GELLER, NL ;

VOGELZANG, NJ ;

CAREY, R ;

AUMAN, J ;

WHITMORE, WF ;

HERR, H ;

MORSE, M ;

SOGANI, P ;

CHAN, E .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) :436-440

[15] A RANDOMIZED TRIAL OF ETOPOSIDE + CISPLATIN VERSUS VINBLASTINE + BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN IN PATIENTS WITH GOOD-PROGNOSIS GERM-CELL TUMORS [J].

BOSL, GJ ;

GELLER, NL ;

BAJORIN, D ;

LEITNER, SP ;

YAGODA, A ;

GOLBEY, RB ;

SCHER, H ;

VOGELZANG, NJ ;

AUMAN, J ;

CAREY, R ;

FAIR, WR ;

HERR, H ;

MORSE, M ;

SOGANI, P ;

WHITMORE, W .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1231-1238

[16] SERUM TUMOR-MARKERS IN PATIENTS WITH METASTATIC GERM-CELL TUMORS OF THE TESTIS - A 10-YEAR EXPERIENCE [J].

BOSL, GJ ;

GELLER, NL ;

CIRRINCIONE, C ;

NISSELBAUM, J ;

VUGRIN, D ;

WHITMORE, WF ;

GOLBEY, RB .

AMERICAN JOURNAL OF MEDICINE, 1983, 75 (01) :29-35

[17]

BOSL GJ, 1990, JNCI-J NATL CANCER I, V82, P221

[18] STEEL-DICKIE MUTATION ENCODES A C-KIT LIGAND LACKING TRANSMEMBRANE AND CYTOPLASMIC DOMAINS [J].

BRANNAN, CI ;

LYMAN, SD ;

WILLIAMS, DE ;

EISENMAN, J ;

ANDERSON, DM ;

COSMAN, D ;

BEDELL, MA ;

JENKINS, NA ;

COPELAND, NG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4671-4674

[19]

BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480

[20] DRUG-RESISTANCE PATTERNS ASSESSED FROM TUMOR-MARKER ANALYSIS [J].

CARL, J .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (21) :1631-1639

← 1 2 3 4 5 6 7 8 9 10 →